Market Cap 5.75M
Revenue (ttm) 27.38M
Net Income (ttm) -167.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -613.40%
Debt to Equity Ratio 0.00
Volume 118,703,398
Avg Vol 26,170,799
Day's Range N/A - N/A
Shares Out 154.59M
Stochastic %K 6%
Beta 1.91
Analysts Sell
Price Target $1.00

Company Profile

Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., designs, develops, manufactures, and sells radio frequency (RF) filter products for the wireless industry in the Americas, Asia, Europe, and internationally. It operates in two segments, Fabrication Services and RF Filters. The Fabrication Services segment provides engineering review and backend packaging services. The RF Filters segment sells amplifier and filter products. It offers RF filters for the wireless industry, such a...

Industry: Communication Equipment
Sector: Technology
Phone: 704 997 5735
Fax: 704 997 5734
Address:
9805 Northcross Center Court, Suite A, Huntersville, United States
RadioIsotope25
RadioIsotope25 Jan. 27 at 2:58 PM
Alpha- vs Beta-Radiopharmaceuticals Impact Immune Checkpoints Differently $AKTS $RADX $CATX https://bioengineer.org/alpha-vs-beta-radiopharmaceuticals-impact-immune-checkpoints-differently/
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 26 at 10:50 PM
$AKTS Nice reversal today
0 · Reply
Billonstart
Billonstart Jan. 26 at 6:13 AM
$AKTS It is Great company. It will go to the moon.
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 23 at 11:37 PM
Radiopharmaceuticals are on the rise as drug developers realize enormous potential | TRACER $RADX $AKTS https://www.tracercro.com/resources/blogs/radiopharmaceuticals-are-on-the-rise-as-drug-developers-realize-enormous-potential/
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 23 at 12:27 PM
$AKTS sorry was for $AKTX **************
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 23 at 12:26 PM
$AKTS need to make a change to u * creating issues for the other stocksso will move u out the way
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 22 at 8:37 PM
0 · Reply
cor1
cor1 Jan. 22 at 6:11 PM
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 22 at 5:51 PM
$BCYC is a similar comparable to $RADX and their valuation is 8x and $AKTS is 20x…
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 22 at 5:39 PM
En Fuego $AKTS $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 27 at 2:58 PM
Alpha- vs Beta-Radiopharmaceuticals Impact Immune Checkpoints Differently $AKTS $RADX $CATX https://bioengineer.org/alpha-vs-beta-radiopharmaceuticals-impact-immune-checkpoints-differently/
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 26 at 10:50 PM
$AKTS Nice reversal today
0 · Reply
Billonstart
Billonstart Jan. 26 at 6:13 AM
$AKTS It is Great company. It will go to the moon.
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 23 at 11:37 PM
Radiopharmaceuticals are on the rise as drug developers realize enormous potential | TRACER $RADX $AKTS https://www.tracercro.com/resources/blogs/radiopharmaceuticals-are-on-the-rise-as-drug-developers-realize-enormous-potential/
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 23 at 12:27 PM
$AKTS sorry was for $AKTX **************
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 23 at 12:26 PM
$AKTS need to make a change to u * creating issues for the other stocksso will move u out the way
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 22 at 8:37 PM
0 · Reply
cor1
cor1 Jan. 22 at 6:11 PM
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 22 at 5:51 PM
$BCYC is a similar comparable to $RADX and their valuation is 8x and $AKTS is 20x…
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 22 at 5:39 PM
En Fuego $AKTS $RADX
0 · Reply
3thefischer
3thefischer Jan. 22 at 10:51 AM
$AKTS I had a 20K possision which i liquidated early 2025 f0r 200Bucks 🫠
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 21 at 11:52 PM
Rad101 shows tumors that MRI’s can’t. 300,000 patient population.. would be 3rd largest revenue radiopharmaceutical imaging agent in world. $RADX $LNTH $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 21 at 6:43 PM
$RADX Re: Lantheus- 20:24 from Conf today; Uh they are the largest investor with 15% of the company, Um they don’t have a board seat. They don’t have first right of refusal. So they play the investor roles. They are a five billion dollar company. So they are looking at our products and I am sure they are interested in many of them. Our job is to advance and prove products can be successful and potentially that collaboration can go. $LNTH $AKTS
1 · Reply
RadioIsotope25
RadioIsotope25 Jan. 21 at 3:42 PM
Radiopharm Theranostics, Ltd. (NASDAQ: $RADX) (ASX: RAD) - YouTube $AKTS $IBRX $IOVA $LNTH https://www.youtube.com/watch?v=XVL6708YTvU
1 · Reply
RadioIsotope25
RadioIsotope25 Jan. 21 at 3:30 PM
$RADX $60,000,000 ——————— $1,000,000,000 $AKTS
0 · Reply
FilingTracker
FilingTracker Jan. 20 at 10:49 PM
$AKTS Ansbert Gadicke revealed a 19.3% ownership stake: https://www.sec.gov/Archives/edgar/data/1729505/000123191926000070/xslSCHEDULE_13D_X01/primary_doc.xml
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 20 at 4:51 PM
Worth a minimum $9.30 that’s what Lantheus paid. If rad202 shows meaningful response at 75 mci this can be asymmetrical… No borrow Same warheads as pluvicto and Lutathera Ceo comes from Novartis Market cap tiny at $60 million when Aktis sits over a billion. Rad101 already has great phase 2 b data and they gonna start phase 3 in 4th quarter. $750 million global imaging asset. $IOVA $LNTH $IBRX $AKTS
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 20 at 3:10 AM
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 17 at 2:20 PM
RAD202 HER2 LU-177 is a nanobody. Exploring the Power of Nanobodies to Fight Cancer & Other Diseases - YouTube $AKTS $RADX $IBRX $VNDA https://www.youtube.com/watch?v=BFUvkW1FN7Y
1 · Reply
RadioIsotope25
RadioIsotope25 Jan. 14 at 3:10 PM
Rad202 $8-9 billion per year drug $RADX $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 14 at 2:14 AM
The Medicine Maker | The Future of Precision Medicine is Radiopharmaceuticals $RADX $AKTS https://themedicinemaker.com/issues/2026/articles/january/the-future-of-precision-medicine-is-radiopharmaceuticals/
0 · Reply
AZOZ
AZOZ Jan. 13 at 12:18 PM
$AKTS Insider loading big Stay tuned!
0 · Reply